Long Covid

A new study covered by CIDRAP suggests COVID-19 may worsen pre-existing health problems over the long term, adding to the growing body of research on the virus's lasting effects. Commenters sharing the findings note the pandemic is far from over and argue the results underscore the need for continued public health vigilance around SARS-CoV-2 and its chronic consequences.

A new study suggests that COVID-19 may worsen pre-existing health problems over the long term, adding to concerns about the lasting effects of infection. The finding points to a broader long-term health burden beyond long COVID itself, with implications for patients managing chronic conditions and for health systems assessing ongoing care needs.

A new study indicates healthcare workers are battling persistent long COVID symptoms, with many continuing to experience fatigue, brain fog and other lasting effects well after infection. The findings highlight the ongoing toll of the pandemic on medical staff, raising concerns about workforce shortages and the need for better support and treatment for affected clinicians.

A new cross-sectional study published in Nature examines the risk factors associated with post-COVID-19 symptoms in patients with asthma and chronic obstructive pulmonary disease. The research aims to identify which characteristics make people with these chronic lung conditions more likely to experience lingering symptoms after infection, a question of ongoing concern for respiratory clinicians.

Ontario is rolling out Covid and flu vaccinations beginning September 28 for priority groups, including hospital patients and staff, people aged 65 and older, and residents and staff of long-term care homes, retirement homes and similar settings. The early access is aimed at protecting the most vulnerable before the wider respiratory illness season, with broader eligibility for the general public expected to follow later.

A US Senate committee has voted to hold Dr. Anthony Fauci in contempt of Congress, escalating a long-running effort by Republican lawmakers to investigate his role in the federal response to Covid-19. The vote follows Fauci's refusals to comply with committee demands, including requests for testimony and records related to pandemic-era decisions and federal research funding. The move now heads toward a possible full Senate or Justice Department decision on enforcement.

Covid cases in Italy have doubled within a month, according to reports circulating in Italian media. Commentators note that for most people the current infection resembles a common cold, while so-called long Covid sequelae are now less frequent. Discussion is focused on whether the summer uptick warrants renewed caution or simply reflects an endemic seasonal virus.

New findings show that some people with Long Covid carry autoantibodies targeting neuronal cells, but no consistent antibody signature has been identified across patients. Commenters say the picture is heterogeneous, meaning the immune response differs from person to person. Many note this fits expectations that Long Covid and ME/CFS have an autoimmune component without being classic autoimmune diseases like multiple sclerosis.

New coverage of vaccine research highlights a consistent finding: vaccination reduces the risk of developing Long Covid. However, studies differ considerably in estimating the size of that reduction, leaving uncertainty about exactly how protective vaccination is against the lasting symptoms that can follow infection. Health observers are weighing the varying figures as vaccine policy debates continue.

Public health messaging circulating online is reminding people that COVID-19 remains a risk even for those who have never been infected or who recovered without complications. The warnings stress that reinfection is possible, Long COVID can follow even mild cases, and the same infection can affect different people very differently.

Researchers at WashU Medicine say influenza, like COVID-19, can produce lasting symptoms that persist for months after infection, a condition being called 'long flu'. They are advising people on ways to lower their risk, including vaccination and prompt treatment. The findings add flu to the growing list of viruses linked to prolonged illness.

MPR News reports that many Minnesotans are still living with long COVID years after the pandemic began, with symptoms continuing to disrupt work and daily life. The story highlights how the lingering illness remains a public health concern even as emergency-era attention to COVID-19 has faded.

After weeks of uncertainty and delays, the federal government has begun distributing COVID-19 vaccines for children from low-income families. The move ends a limbo that had left many families and clinics waiting for doses, and it raises questions about what caused the holdup and whether supply will now reach providers reliably.

Researchers with the National Institutes of Health report that an antiviral drug did not improve symptoms in patients with Long COVID. The finding comes from a federally funded trial and adds to a string of disappointing results in the search for effective treatments for the lingering condition, which affects millions of people worldwide. Clinicians and patient advocates say the result underscores how little proven therapy exists for the illness.